Bhutan vs Ukraine: The number of people with susceptibility test result for rifampicin
Bhutan
96.77
in 2021
Ukraine
97.48
in 2021
Bhutan rank
40th
Ukraine rank
39th
The number of people with susceptibility test result for rifampicin over time
- Bhutan
- Ukraine
How they compare
Ukraine currently reports 97.48 against 96.77 in Bhutan, a difference of 0.71.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Ukraine ahead.
Bhutan ranks 40th and Ukraine ranks 39th of 146 countries.
Across the 2 decades both report, Bhutan averaged higher in 1 and Ukraine in 1.
Head to head by decade
| Decade | Bhutan | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.89 | 95.6 | 1.71 | Ukraine |
| 2020s | 98.38 | 97.36 | 1.02 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bhutan or Ukraine?
- Ukraine, at 97.48 against 96.77 in Bhutan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bhutan and Ukraine?
- 0.71, with Ukraine ahead.
- How many years of comparable data are there for Bhutan and Ukraine?
- 5 years are reported by both, from 2017 to 2021.
- How do Bhutan and Ukraine rank globally for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 40th and Ukraine ranks 39th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.